(US) /    Tel: (781) 999-4286 / (781) 999-5354
Home > HER2
Cat.No. Product Name Information Area
T4014 CP-724714 CP-724714 is an effective and selective HER2/ErbB2 inhibitor (IC50: 10 nM), >640-fold... Others
T2501 Canertinib dihydrochloride Canertinib dihydrochloride is the hydrochloride salt of an orally bio-available quina... Cancer
T6235 Lapatinib (GW-572016) Ditosylate Lapatinib Ditosylate, an effective EGFR and ErbB2 inhibitor, is with IC50 of 10.8 an... Cancer
T6124 Mubritinib (TAK 165)new Mubritinib (TAK-165) is a potent inhibitor of HER2/ErbB2 with IC50 of 6 nM. Cancer
T6092 AZD8931 (Sapitinib) AZD8931, a reversible, ATP competitive inhibitor of EGFR(IC50=4 nM), ErbB2(IC50=3 nM)... Cancer
T2630 Poziotinib Poziotinib(NOV120101; HM781-36B) is an irreversible HER1/2/4 inhibitor (IC50s: 3/5/23... Cancer
T2610 BMS-599626 BMS-599626 has been used in trials studying the treatment of Cancer, Metastases, and ... Cancer
T2600 AG-490 AG-490 (Tyrphostin AG 490) is an inhibitor of EGFR (IC50: 0.1 μM). It is 135-fold mor... Other
T2518 ARRY-380 ARRY-380 is a potent and selective HER2 inhibitor. Cancer
T2483 Dacomitinib (PF299804, PF299) Dacomitinib(PF299804; PF-00299804) is a highly selective, orally bioavailable small-m... Cancer
T2364 Irbinitinib Irbinitinib(ARRY-380; ONT-380) is a potent and selective HER2 inhibitor (IC50: 8 nM). Cancer
T2327 Pelitinib Pelitinib (EKB-569) is an effective irreversible EGFR inhibitor (IC50: 38.5 nM). Cancer
T2325 Neratinib Neratinib (HKI-272) is an orally available, irreversible tyrosine kinase inhibitor (I... Cancer
T2116 AEE788 AEE788 has been used in trials studying the treatment of Cancer, Glioblastoma Multifo... Cancer
T2047 AG-1478 AG-1478 (Tyrphostin AG-1478) is a selective EGFR inhibitor. Cancer
T1773 Afatinib (BIBW2992) Dimaleate Afatinib is an orally bioavailable anilino-quinazoline derivative and inhibitor of th... Cancer
T0078L Lapatinib ditosylate monohydrate Lapatinib is a tyrosine kinase receptor inhibitor used in the therapy of advanced bre... Cancer
T0078 Lapatinib Lapatinib(GW-572016) is an effective ErbB2 and EGFR inhibitor with IC50 of 9.2 and 1... Cancer